Soluble tumor necrosis factor-α receptor type II (sTNFaRII) correlates with human immunodeficiency virus (HIV) RNA copy number in HIV-infected patients

Journal of Infectious Diseases

Volumn 173, Issue 2, 1996, Pages 464-467

  Bilello, John A ^a   Stellrecht, Kathleen ^b   Drusano, George L ^b   Stein, Daniel S ^b  

^a ALBANY MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; VIRUS RNA;

ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; T LYMPHOCYTE; VIRUS REPLICATION;

CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, VIRAL; SOLUBILITY; VIREMIA;

EID: 0030071867     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.2.464     Document Type: Article

References (15)

1. Tartaglia LA, Goedell DV. Two TNF receptors. Immunol Today 1992;13:151-3.
2. Brouckaert P, Libert C, Everaerut B, Takahashi N, Cauwels A, Fiers W. Tumor necrosis factor, its receptors and the connection with interleukin-1 and interleukin-6. Immunobiology 1993;152:1362-9.
3. Diez-Ruiz A, Tilz GP, Zangerle R, Baier-Bitterlich G, Wachter H, Fuchs D. Soluble receptors for tumor necrosis factor in clinical laboratory diagnosis. Eur J Haematol 1995;54:1-8.
4. + lymphocytes. Clin Exp Immunol 1993;93:350-5.
5. Ankrust P, Liabakk NB, Mueller F, Lien E, Espevik T, Froeland SS. Serum levels of tumor necrosis factor-α (TNFα) and soluble TNF receptors in human immunodeficiency virus type 1 infection - correlations to clinical, immunologic, and virologie parameters. J Infect Dis 1994;169:420-4.
6. Zangerle R, Gallati H, Sarcletti M, et al. Increased serum concentrations of soluble tumor necrosis factor receptors in HIV-infected individuals are associated with immune activation. J Acquir Immune Defic Syndr 1994;7:79-85.
7. Gotfried MH, van der Poll T, Jansen J, et al. Soluble receptors for tumor necrosis factor: a putative marker of disease progression in HIV infection. AIDS 1993;7:33-6.
8. Gotfried MH, van der Poll T, Weverling GJ, et al. Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection. J Infect Dis 1994;169:739-45.
9. Mellors JW, Kingsley LA, Rinaldo CR Jr, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995:122:573-9.
10. Hogervorst E, Jurriaans S, de Wolf F, et al. Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels. J Infect Dis 1995;171:811-21.
11. NIAID Division of AIDS Flow Cytometry Advisory Committee. Guidelines for flow cytometric immunotyping. Version 1. Bethesda, MD: National Institutes of Health, 1993.
12. Mulder J, McKinney N, Christopherson C, et al. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J Clin Microbiol 1994;32:292-300.
13. Stein DS, Korvick JA, Vermund SH. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus disease: a review. J Infect Dis 1992;165:352-63.
14. Mole L, Margolis D, Carroll R, Todd J, Holodniy M. Stabilities of quantitative plasma culture for human immunodeficiency virus, RNA, and p24 antigen from samples collected in VACUTAINER CPT and standard VACUTAINER tubes. J Clin Microbiol 1994;32:2212-5.
15. Lin HJ, Myers LE, Yen-Lieberman B, et al. Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. J Infect Dis 1994;170:553-62.